Huntington National Bank Altimmune, Inc. Transaction History
Huntington National Bank
- $12.3 Billion
- Q1 2024
A detailed history of Huntington National Bank transactions in Altimmune, Inc. stock. As of the latest transaction made, Huntington National Bank holds 2 shares of ALT stock, worth $13. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 2
-0.0%
Holding current value
$13
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ALT
# of Institutions
185Shares Held
44.4MCall Options Held
1.1MPut Options Held
647K-
State Street Corp Boston, MA8.65MShares$57.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.04MShares$26.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.13MShares$20.8 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$18.3 Million3.41% of portfolio
-
Morgan Stanley New York, NY2.21MShares$14.7 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $326M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...